Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.73 USD | -1.64% | -2.09% | -20.00% |
Financials (USD)
Sales 2024 * | 114M | Sales 2025 * | 4.17M | Capitalization | 168M |
---|---|---|---|---|---|
Net income 2024 * | -71M | Net income 2025 * | -188M | EV / Sales 2024 * | 2.06 x |
Net Debt 2024 * | 67.55M | Net Debt 2025 * | 127M | EV / Sales 2025 * | 70.6 x |
P/E ratio 2024 * |
-1.86
x | P/E ratio 2025 * |
-0.98
x | Employees | 135 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.05% |
Latest transcript on Gossamer Bio, Inc.
1 day | -1.64% | ||
1 week | -3.36% | ||
Current month | +2.82% | ||
1 month | -14.93% | ||
3 months | -29.13% | ||
6 months | -9.95% | ||
Current year | -20.00% |
Managers | Title | Age | Since |
---|---|---|---|
Faheem Hasnain
CEO | Chief Executive Officer | 65 | 15-10-24 |
Bryan Giraudo
DFI | Director of Finance/CFO | 48 | 18-05-06 |
Chief Tech/Sci/R&D Officer | - | 23-10-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Faheem Hasnain
CEO | Chief Executive Officer | 65 | 15-10-24 |
Thomas Daniel
BRD | Director/Board Member | 69 | 17-12-31 |
Skye Drynan
BRD | Director/Board Member | - | Mar. 10 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.08% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 0.73 | -1.64% | 1,211,387 |
24-05-15 | 0.7422 | +1.28% | 1,988,593 |
24-05-14 | 0.7328 | +1.78% | 2,608,330 |
24-05-13 | 0.72 | -3.00% | 1,362,935 |
24-05-10 | 0.7423 | -0.44% | 1,049,955 |
Delayed Quote Nasdaq, May 16, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.00% | 168M | |
+33.37% | 49.46B | |
+1.55% | 42.58B | |
+49.11% | 42.49B | |
-4.22% | 29.09B | |
+11.57% | 26.61B | |
-21.00% | 18.64B | |
+7.36% | 13.16B | |
+28.30% | 12.55B | |
+23.80% | 12.1B |
- Stock Market
- Equities
- GOSS Stock